Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib

Tekijä Stjepanovic, Neda, Capdevila, Jaume
Julkaistu 2014

Unmet Needs in the Field of Neuroendocrine Neoplasms of the Gastrointestinal Tract, Pancreas, and Respiratory System: Reports by the ENETS Group

Tekijä de Herder, Wouter W., Capdevila, Jaume
Julkaisussa Neuroendocrinology (2019)

Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies

Tekijä Grande, Enrique, Díez, Juan José, Zafon, Carles, Capdevila, Jaume
Julkaistu 2012

Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer

Tekijä Gupta, Anubha, Jarzab, Barbara, Capdevila, Jaume, Shumaker, Robert, Hussein, Ziad
Julkaisussa Br J Clin Pharmacol (2016)

A significant response to sunitinib in a patient with anaplastic thyroid carcinoma

Tekijä Grande, Enrique, Capdevila, Jaume, Díez, Juan José, Longo, Federico, Carrato, Alfredo
Julkaistu 2013

Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report

Tekijä Cortés-Mateus, Karen S., Holub, Katarzyna, Racca, Fabricio, Grau, Juan José, Capdevila, Jaume
Julkaisussa Oncol Lett (2018)

Meta‐Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors

Tekijä Capdevila, Jaume, Hernando, Jorge, Perez‐Hoyos, Santiago, Roman‐Gonzalez, Alejandro, Grande, Enrique
Julkaisussa Oncologist (2019)

Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis...

Tekijä Sevilla, Isabel, Segura, Ángel, Capdevila, Jaume, López, Carlos, García-Carbonero, Rocío, Grande, Enrique
Julkaisussa BMC Cancer (2016)

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

Tekijä Grande, Enrique, Kreissl, Michael C., Filetti, Sebastiano, Newbold, Kate, Reinisch, Walter, Robert, Caroline, Schlumberger, Martin, Tolstrup, Lærke K., Zamorano, Jose L., Capdevila, Jaume
Julkaistu 2013

Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-3 Trial

Tekijä Lombard-Bohas, Catherine, Yao, James C., Hobday, Timothy, Van Cutsem, Eric, Wolin, Edward M., Panneerselvam, Ashok, Stergiopoulos, Sotirios, Shah, Manisha H., Capdevila, Jaume, Pommier, Rodney
Julkaisussa Pancreas (2015)

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in dev...

Tekijä Garcia-Carbonero, Rocio, Garcia-Figueiras, Roberto, Carmona-Bayonas, Alberto, Sevilla, Isabel, Teule, Alex, Quindos, Maria, Grande, Enrique, Capdevila, Jaume, Aller, Javier, Arbizu, Javier, Jimenez-Fonseca, Paula
Julkaisussa Cancer Metastasis Rev (2015)

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents

Tekijä García-Alfonso, Pilar, Ferrer, Ana, Gil, Silvia, Dueñas, Rosario, Pérez, María Teresa, Molina, Raquel, Capdevila, Jaume, Safont, María José, Castañón, Carmen, Cano, Juana María, Lara, Ricardo
Julkaisussa Target Oncol (2015)

Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT

Tekijä Molla, Meritxell, Fernandez-Plana, Julen, Albiol, Santiago, Fondevila, Constantino, Vollmer, Ivan, Cases, Carla, Garcia-Criado, Angeles, Capdevila, Jaume, Conill, Carles, Fundora, Yliam, Fernandez-Martos, Carlos, Pineda, Estela
Julkaisussa J Clin Med (2021)

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

Tekijä Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J., Dutcus, Corina E., Song, James, Taylor, Matthew H., Kim, Sung-Bae, Krzyzanowska, Monika K., Capdevila, Jaume, Sherman, Steven I., Tahara, Makoto
Julkaisussa J Clin Endocrinol Metab (2016)

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

Tekijä Capdevila, Jaume, Teulé, Alexandre, Barriuso, Jorge, Castellano, Daniel, Lopez, Carlos, Manzano, Jose Luis, Alonso, Vicente, García‐Carbonero, Rocío, Dotor, Emma, Matos, Ignacio, Custodio, Ana, Casanovas, Oriol, Salazar, Ramon
Julkaisussa Oncologist (2018)

Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review

Tekijä Grande, Enrique, Díaz, Ángel, López, Carlos, Munarriz, Javier, Reina, Juan-José, Vera, Ruth, Bernárdez, Beatriz, Aller, Javier, Capdevila, Jaume, Garcia-Carbonero, Rocio, Jimenez Fonseca, Paula, Trapero-Bertran, Marta
Julkaisussa Ther Adv Endocrinol Metab (2019)

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

Tekijä Garcia‐Carbonero, Rocio, Marquez‐Rodas, Ivan, de la Cruz‐Merino, Luis, Martinez‐Trufero, Javier, Cabrera, Miguel Angel, Piulats, Jose Maria, Capdevila, Jaume, Grande, Enrique, Martin‐Algarra, Salvador, Berrocal, Alfonso
Julkaisussa Oncologist (2019)

Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey...

Tekijä Benavent, Marta, Sastre, Javier, Escobar, Ignacio García, Segura, Angel, Capdevila, Jaume, Carmona, Alberto, Sevilla, Isabel, Alonso, Teresa, Crespo, Guillermo, García, Lourdes, Canal, Neus, de la Cruz, Guillermo, Gallego, Javier
Julkaisussa Health Qual Life Outcomes (2021)

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor — an update on neuroendocrine neoplasm’s treatment: A case report

Tekijä Mirallas, Oriol, Saoudi, Nadia, Gómez-Puerto, Diego, Riveiro-Barciela, Mar, Merino, Xavier, Auger, Cristina, Landolfi, Stefania, Blanco, Laia, Garcia-Burillo, Amparo, Molero, Xavier, Salcedo-Allende, Maria Teresa, Capdevila, Jaume
Julkaisussa World J Hepatol (2021)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results of the RADIANT-3 Study

Tekijä Pommier, Rodney, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Lam, Du, Kunz, Tiffany, Brandt, Ulrike, Capdevila, Jaume, De Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Yao, James C.
Julkaisussa Gastrointest Cancer Res (2014)